Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
The Schmooze

Pill Makes Fasting Easier

Israeli Arabs may soon make your Yom Kippur fast easier.

It’s often said that Jews and Muslims have a lot in common when it comes to religious observance, and that’s rarely highlighted better than when it comes to fasting. Both religions require full-on fasting several times a year.

Now there’s a theory that a drug called etoricoxib (commercial name Arcoxia), if taken before a fast day, reduces the occurrence of migraines and headaches. Before Yom Kippur, doctors at Jerusalem’s Shaare Zedek Medical Center gave 211 patients pills to take — some were placebos, others were etoricoxib. Those who took the real thing — which conveniently remains active in the body for 22 hours — reported an easier fast.

The same researchers are working with Muslims who are fasting through Ramadan to continue their research, and if all goes well, they may just find a cure to fast-related migraines. On their recruitment website, they present the participation in the research as a religious virtue, as it will test whether the drug will “decrease the incidence of people breaking their fast.” You can see more on the experiment in this piece in the Jerusalem Post.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.

If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.

Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism. 

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.